Zeo ScientifiX (ZEOX) Accumulated Expenses (2013 - 2026)
Zeo ScientifiX (ZEOX) posted quarterly Accumulated Expenses of $107000.0 for Q2 2026, down 32.28% year-over-year from $158000.0 in Q2 2025, and up 78.33% quarter-over-quarter from $60000.0 in Q1 2026.
Zeo ScientifiX (ZEOX) Accumulated Expenses (2013 - 2026) Analysis & Trends
Zeo ScientifiX's Accumulated Expenses history runs 14 years deep, the most recent figure standing at $107000.0 for Q2 2026.
- In Q2 2026, Accumulated Expenses fell 32.28% year-over-year to $107000.0; the TTM figure through Apr 2026 stood at $107000.0 (down 32.28% YoY), while the FY2025 annual figure was $1000.0, down 99.85% from the prior year.
- Accumulated Expenses for Q2 2026 stood at $107000.0, up from $60000.0 in the prior quarter.
- The five-year high for Accumulated Expenses was $1.7 million in Q1 2022, with the low at $1000.0 in Q4 2025.
- The 5-year median for Accumulated Expenses is $666780.0 (2022), against an average of $486894.8.
- The sharpest annual moves came in 2024 and 2025: Accumulated Expenses surged 529.25% in 2024, then slumped 99.85% in 2025.
- Zeo ScientifiX's Accumulated Expenses stood at $666780.0 in 2022, then slumped by 84.1% to $106000.0 in 2023, then soared by 529.25% to $667000.0 in 2024, then plunged by 99.85% to $1000.0 in 2025, then soared by 10600.0% to $107000.0 in 2026.
- Business Quant data shows ZEOX's Accumulated Expenses at $107000.0 in Q2 2026, $60000.0 in Q1 2026, and $1000.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 107,000.00 |
| Jan 31, 2026 | 60,000.00 |
| Oct 31, 2025 | 1,000.00 |
| Jul 31, 2025 | 667,000.00 |
| Apr 30, 2025 | 158,000.00 |
| Jan 31, 2025 | 151,000.00 |
| Oct 31, 2024 | 667,000.00 |
| Jul 31, 2024 | 142,000.00 |
| Apr 30, 2024 | 667,000.00 |
| Jan 31, 2024 | 667,000.00 |
| Oct 31, 2023 | 106,000.00 |
| Jul 31, 2023 | 666,780.00 |
| Apr 30, 2023 | 666,780.00 |
| Jan 31, 2023 | 666,780.00 |
| Oct 31, 2022 | 666,780.00 |
| Jan 31, 2022 | 1.73 Mn |
| Oct 31, 2021 | 504,979.00 |
| Jul 31, 2021 | 1.33 Mn |
| Apr 30, 2021 | 1.27 Mn |
| Jan 31, 2021 | 1.40 Mn |